Exploring the role of miRSNPs in diagnosis and prognosis of prostate cancer
This study will conjoin the well-established mechanism of miRNA regulation in the prostate cancer aetiology with the unexplored area of regulatory genetic variants in untranslated gene regions to yield clinically-relevant information. Dr Batra proposes to undertake an innovative approach by combining expertise in genetic, molecular and computational biology. Alongside increasing our understanding of cancer biology, these results will provide an impetus for future diagnostic genetic tests for cancer risk assessment and prevention management and would be first step towards miRNA-based pharmacogenomics.
Investigators
| Jyotsna Batra | APCRC-Q, IHBI, QUT, TRI |
Duration
2015 - 2017
Funding
| NHMRC Career Development Fellowship | $411 768 |
